发明人唐晓军,胡光,孙丽萍. "Method for the Synthesis of Crizotinib Impurity 53" [P]. 中国发明专利, 专利号 CN 109030760 B, 授权公告日 2020-11-26.
发明人张德明,何建平,唐晓军. "A Process for Preparing High-Purity Crizotinib Impurity 53" [P]. 中国发明专利, 专利号 CN 115984104 A, 授权公告日 2024-02-14.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质53 in Pharmaceutical Formulations". J. Nat. Prod., 2025, 877, (7), 9963-9977.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质53 as an Impurity". Phytochemistry, 2023, 971, 8999-9016.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 53 Using HRMS and NMR". J. Sep. Sci., 2023, 1796, (8), 8378-8388.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 克唑替尼杂质53 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2014, 1096, (2), 1215-1218.